Federal Register / Vol. 79, No. 112 / Wednesday, June 11, 2014 / Rules and Regulations 33465 

as the stoichiometric equivalent of 

spirodiclofen. 

* * * * * 

[FR Doc. 2014–13233 Filed 6–10–14; 8:45 am] 

BILLING CODE 6560–50–P 

ENVIRONMENTAL PROTECTION 

AGENCY 

40 CFR Part 180 

[EPA–HQ–OPP–2012–0903; FRL–9910–39] 

Tricyclazole; Pesticide Tolerances 

AGENCY: Environmental Protection 

Agency (EPA). 

ACTION: Final rule. 

SUMMARY: This regulation establishes 

tolerances for residues of tricyclazole in 

or on imported rice. Dow AgroSciences, 

LLC, requested these tolerances under 

the Federal Food, Drug, and Cosmetic 

Act (FFDCA). 

DATES: This regulation is effective June 

11, 2014. Objections and requests for 

hearings must be received on or before 

August 11, 2014, and must be filed in 

accordance with the instructions 

provided in 40 CFR part 178 (see also 

Unit I.C. of the SUPPLEMENTARY

INFORMATION). 

ADDRESSES: The docket for this action, 

identified by docket identification (ID) 

number EPA–HQ–OPP–2012–0903, is 

available at http://www.regulations.gov 

or at the Office of Pesticide Programs 

Regulatory Public Docket (OPP Docket) 

in the Environmental Protection Agency 

Docket Center (EPA/DC), West William 

Jefferson Clinton Bldg., Rm. 3334, 1301 

Constitution Ave. NW., Washington, DC 

20460–0001. The Public Reading Room 

is open from 8:30 a.m. to 4:30 p.m., 

Monday through Friday, excluding legal 

holidays. The telephone number for the 

Public Reading Room is (202) 566–1744, 

and the telephone number for the OPP 

Docket is (703) 305–5805. Please review 

the visitor instructions and additional 

information about the docket available 

at http://www.epa.gov/dockets. 

FOR FURTHER INFORMATION CONTACT: Lois 

Rossi, Registration Division (7505P), 

Office of Pesticide Programs, 

Environmental Protection Agency, 1200 

Pennsylvania Ave. NW., Washington, 

DC 20460–0001; telephone number: 

(703) 305–7090; email address: 

RDFRNotices@epa.gov. 

SUPPLEMENTARY INFORMATION: 

I. General Information 

A. Does this action apply to me? 

You may be potentially affected by 

this action if you are an agricultural 

producer, food manufacturer, or 

pesticide manufacturer. The following 

list of North American Industrial 

Classification System (NAICS) codes is 

not intended to be exhaustive, but rather 

provides a guide to help readers 

determine whether this document 

applies to them. Potentially affected 

entities may include: 

• Crop production (NAICS code 111). 

• Animal production (NAICS code 

112). 

• Food manufacturing (NAICS code 

311). 

• Pesticide manufacturing (NAICS 

code 32532). 

B. How can I get electronic access to 

other related information? 

You may access a frequently updated 

electronic version of EPA’s tolerance 

regulations at 40 CFR part 180 through 

the Government Printing Office’s e-CFR 

site at http://www.ecfr.gov/cgi-bin/textidx?&c=ecfr&tpl=/ecfrbrowse/Title40/

40tab_02.tpl. 

C. How can I file an objection or hearing 

request? 

Under FFDCA section 408(g), 21 

U.S.C. 346a, any person may file an 

objection to any aspect of this regulation 

and may also request a hearing on those 

objections. You must file your objection 

or request a hearing on this regulation 

in accordance with the instructions 

provided in 40 CFR part 178. To ensure 

proper receipt by EPA, you must 

identify docket ID number EPA–HQ– 

OPP–2012–0903, in the subject line on 

the first page of your submission. All 

objections and requests for a hearing 

must be in writing, and must be 

received by the Hearing Clerk on or 

before August 11, 2014. Addresses for 

mail and hand delivery of objections 

and hearing requests are provided in 40 

CFR 178.25(b). 

In addition to filing an objection or 

hearing request with the Hearing Clerk 

as described in 40 CFR part 178, please 

submit a copy of the filing (excluding 

any Confidential Business Information 

(CBI)) for inclusion in the public docket. 

Information not marked confidential 

pursuant to 40 CFR part 2 may be 

disclosed publicly by EPA without prior 

notice. Submit the non-CBI copy of your 

objection or hearing request, identified 

by docket ID number EPA–HQ–OPP– 

2012–0903, by one of the following 

methods: 

• Federal eRulemaking Portal: http:// 

www.regulations.gov. Follow the online 

instructions for submitting comments. 

Do not submit electronically any 

information you consider to be CBI or 

other information whose disclosure is 

restricted by statute. 

• Mail: OPP Docket, Environmental 

Protection Agency Docket Center (EPA/ 

DC), (28221T), 1200 Pennsylvania Ave. 

NW., Washington, DC 20460–0001. 

• Hand Delivery: To make special 

arrangements for hand delivery or 

delivery of boxed information, please 

follow the instructions at http://

www.epa.gov/dockets/contacts.html. 

Additional instructions on 

commenting or visiting the docket, 

along with more information about 

dockets generally, is available at 

http://www.epa.gov/dockets. 

II. Summary of Petitioned-For 

Tolerance 

In the Federal Register of January 16, 

2013 (78 FR 3377) (FRL–9375–4), EPA 

issued a document pursuant to FFDCA 

section 408(d)(3), 21 U.S.C. 346a(d)(3), 

announcing the filing of a pesticide 

petition (PP 2E8114) by Dow 

AgroSciences, LLC, 9330 Zionsville 

Road, Indianapolis, IN 46268. The 

petition requested that 40 CFR part 180 

be amended by establishing tolerances 

for residues of the fungicide 

tricyclazole, 5-methyl-1,2,4-triazolo[3.4- 

b] benzothiazole, including its 

metabolites and degradates, in or on rice 

at 3.0 parts per million (ppm). That 

document referenced a summary of the 

petition prepared by Dow AgroSciences, 

LLC, the registrant, which is available in 

the docket, http://www.regulations.gov. 

There were no comments received in 

response to the notice of filing. 

Tricyclazole is a new active 

ingredient and is not currently 

registered or proposed for use in the 

United States. The only anticipated 

exposure to tricyclazole residues is from 

the dietary consumption of imported 

rice. Therefore, acute and chronic 

dietary assessments were conducted for 

tricyclazole residues of concern in food 

only. 

Based upon review of the data 

supporting the petition, EPA has 

determined that the parent compound, 

tricyclazole, is suitable as a residue 

definition for purposes of both tolerance 

enforcement and risk assessment in rice. 

This determination is based on 

tricyclazole being the only major 

residue in rice grain and the observation 

that in samples from field trials with 

quantifiable levels of the alcohol 

metabolite, the metabolite is reduced to 

less than the level of detection upon 

husking. EPA has not revised the 

tolerance proposed by Dow in the notice 

of filing. EPA has added the compliance 

statement which clarifies that only the 

parent compound is to be analyzed for 

enforcement purposes. 


wreier-aviles on DSK6TPTVN1PROD with RULES
33466 Federal Register / Vol. 79, No. 112 / Wednesday, June 11, 2014 / Rules and Regulations 

III. Aggregate Risk Assessment and 

Determination of Safety 

Section 408(b)(2)(A)(i) of FFDCA 

allows EPA to establish a tolerance (the 

legal limit for a pesticide chemical 

residue in or on a food) only if EPA 

determines that the tolerance is ‘‘safe.’’ 

Section 408(b)(2)(A)(ii) of FFDCA 

defines ‘‘safe’’ to mean that ‘‘there is a 

reasonable certainty that no harm will 

result from aggregate exposure to the 

pesticide chemical residue, including 

all anticipated dietary exposures and all 

other exposures for which there is 

reliable information.’’ This includes 

exposure through drinking water and in 

residential settings, but does not include 

occupational exposure. Section 

408(b)(2)(C) of FFDCA requires EPA to 

give special consideration to exposure 

of infants and children to the pesticide 

chemical residue in establishing a 

tolerance and to ‘‘ensure that there is a 

reasonable certainty that no harm will 

result to infants and children from 

aggregate exposure to the pesticide 

chemical residue. . . .’’ 

Consistent with FFDCA section 

408(b)(2)(D), and the factors specified in 

FFDCA section 408(b)(2)(D), EPA has 

reviewed the available scientific data 

and other relevant information in 

support of this action. EPA has 

sufficient data to assess the hazards of 

and to make a determination on 

aggregate exposure for tricyclazole 

including exposure resulting from the 

tolerances established by this action. 

EPA’s assessment of exposures and risks 

associated with tricyclazole follows. 

A. Toxicological Profile 

EPA has evaluated the available 

toxicity data and considered its validity, 

completeness, and reliability as well as 

the relationship of the results of the 

studies to human risk. EPA has also 

considered available information 

concerning the variability of the 

sensitivities of major identifiable 

subgroups of consumers, including 

infants and children. 

In oral rat and dog studies, decreased 

body weight was the primary effect 

observed in the database; in oral mouse 

studies, effects were mainly seen in the 

liver. In rats, decreased body weight was 

the only treatment related effect seen in 

adult animals in the subchronic and 

chronic studies, with body weight 

decreases occurring at a lower dose after 

chronic exposure. Decreased body 

weight was also seen in adult rats in 

developmental and reproduction 

studies. Other effects observed in rats 

included clinical signs (weakness, cold 

body, piloerection) in the 

developmental toxicity study at a dose 

similar to that in the subchronic study 

where decreased body weight was 

noted. Brain weight changes were also 

observed in rats in the chronic study; 

however, due to inconsistency in the 

data the effects were not considered 

treatment related. In dogs, decreased 

body weight was the only treatment 

related effect observed after chronic 

exposure. In mice, mortality was seen 

after 90 days, as well as hematological 

changes (increased WBC, decreased 

lymphocyte count, increased 

neutrophil) and liver effects (increased 

weights, enzymes, and histopathology). 

However, it is noteworthy to mention 

that the 90-day subchronic study was 

considered unacceptable due to 

numerous deficiencies. Increased 

mortality was not observed in other 

toxicity studies in mice. After 10 

months, only liver effects (increased 

weights, microsomal activity, and 

histopathology) were observed in mice 

and no treatment related effects were 

observed after 1 year. However, chronic 

exposure in mice (cancer mouse study), 

resulted in liver effects including, 

increased liver weights and liver 

histopathology (acidophilic 

degeneration and fatty change) at doses 

lower than those producing liver effects 

in the shorter term mouse studies. 

Delayed ossification was observed in 

fetuses in the rabbit developmental 

study while decreased body weight was 

observed in fetuses in the rat 

developmental study. The effects were 

seen in the absence of maternal toxicity 

indicating quantitative susceptibility. In 

the rat reproduction study, offspring 

effects included pup death (post-natal 

day (PND 1–4)), decreases in pup body 

weight, and an increase in the number 

of small pups in the presence of less 

severe maternal toxicity (decreased 

body weight) indicating qualitative 

susceptibility. Although susceptibility 

was observed in the developmental/

reproduction studies, the doses and 

endpoints selected for risk assessment 

are protective and the degree of concern 

for the susceptibility observed in the 

studies is low. The Agency has 

classified tricyclazole as ‘‘Not Likely to 

be Carcinogenic to Humans.’’ There 

were no treatment-related increases in 

tumors observed in the submitted 

carcinogenicity studies in rats and/or 

mice. 

Neurotoxicity (acute, subchronic, and 

developmental) and immunotoxicity 

studies are not available for tricyclazole. 

However, EPA, using a weight of the 

evidence (WOE) approach, concluded 

that these studies are not required. 

Dermal toxicity and dermal penetration 

studies are also not available for 

tricyclazole. However, these studies are 

not required to support import 

tolerances. 

Specific information on the studies 

received and the nature of the adverse 

effects caused by tricyclazole as well as 

the no-observed-adverse-effect-level 

(NOAEL) and the lowest-observedadverse-effect-level (LOAEL) from the 

toxicity studies can be found at http:// 

www.regulations.gov on pages 22–28, in 

the document titled, ‘‘Tricyclazole: 

Human Health Risk Assessment for the 

Establishment of Tolerances with No 

U.S. Registration for the New Fungicide 

in/on Imported Rice’’ in docket ID 

number EPA–HQ–OPP–2012–0903. 

B. Toxicological Points of Departure/

Levels of Concern 

Once a pesticide’s toxicological 

profile is determined, EPA identifies 

toxicological points of departure (POD) 

and levels of concern (LOC) to use in 

evaluating the risk posed by human 

exposure to the pesticide. For hazards 

that have a threshold below which there 

is no appreciable risk, the toxicological 

POD is used as the basis for derivation 

of reference values for risk assessment. 

PODs are developed based on a careful 

analysis of the doses in each 

toxicological study to determine the 

dose at which no adverse effects are 

observed (the NOAEL) and the lowest 

dose at which adverse effects of concern 

are identified (the LOAEL). Uncertainty/ 

safety factors are used in conjunction 

with the POD to calculate a safe 

exposure level—generally referred to as 

a population-adjusted dose (PAD) or a 

reference dose (RfD)—and a safe margin 

of exposure (MOE). For non-threshold 

risks, the Agency assumes that any 

amount of exposure will lead to some 

degree of risk. Thus, the Agency 

estimates risk in terms of the probability 

of an occurrence of the adverse effect 

expected in a lifetime. For more 

information on the general principles 

EPA uses in risk characterization and a 

complete description of the risk 

assessment process, see http://

www.epa.gov/pesticides/factsheets/

riskassess.htm. 

Since the proposed uses of 

tricyclazole are all non-domestic, there 

is no potential for drinking water, 

occupational, and/or residential 

exposure, and the only anticipated 

exposure to tricyclazole is dietary 

exposure through consumption of 

imported rice. Therefore, endpoints and 

PODs were only selected for acute and 

chronic dietary risk assessment. 

For acute dietary risk assessment (all 

populations including females 13–49), 

the no observed adverse effect level 

(NOAEL) of 7 milligrams/kilogram/day 

(mg/kg/day) was selected from a 


wreier-aviles on DSK6TPTVN1PROD with RULES
Federal Register / Vol. 79, No. 112 / Wednesday, June 11, 2014 / Rules and Regulations 33467 

reproduction study in rats. An increased 

incidence of pup death was seen at the 

lowest observed adverse effect level 

(LOAEL) of 26.7 mg/kg/day. Decreased 

pup weight and small pups were also 

observed at the LOAEL but were not 

considered to be single dose effects. 

For chronic dietary exposure, a 

NOAEL of 6.67 mg/kg/day was selected 

from a cancer study in mice based on 

liver effects observed at the LOAEL of 

21.8 mg/kg/day. For acute and chronic 

dietary risk assessments, a 100X 

uncertainty factor was applied 

(interspecies factor of 10X and 

intraspecies factor of 10X). 

C. Exposure Assessment 

1. Dietary exposure from food and 

feed uses. In evaluating dietary 

exposure to tricyclazole, EPA 

considered exposure under the 

petitioned-for tolerances. EPA assessed 

dietary exposures from tricyclazole in 

food as follows: 

i. Acute and chronic exposure. Acute 

and chronic dietary (food only) 

exposure assessments were conducted 

with the Dietary Exposure Evaluation 

Model (DEEM–FCID), Version 3.16. This 

software uses 2003–2008 food 

consumption data from the U.S. 

Department of Agriculture’s (USDA’s) 

National Health and Nutrition 

Examination Survey, What We Eat in 

America (NHANES/WWEIA). 

Conservative acute and chronic 

exposure analyses were performed for 

the general U.S. population and 

population subgroups. Recommended 

tolerance-level residues were used to 

estimate dietary exposure. The analyses 

assumed 100% of imported rice is 

treated. 

ii. Cancer. Based on the data 

summarized in Unit III.A., EPA has 

concluded that tricyclazole does not 

pose a cancer risk to humans. Therefore, 

a dietary exposure assessment for the 

purpose of assessing cancer risk is 

unnecessary. 

iii. Anticipated residue and percent 

crop treated (PCT) information. EPA did 

not use anticipated residue and/or PCT 

information in the dietary assessment 

for tricyclazole. Tolerance level residues 

and/or 100% CT were assumed for all 

food commodities. 

2. Cumulative effects from substances 

with a common mechanism of toxicity. 

Section 408(b)(2)(D)(v) of FFDCA 

requires that, when considering whether 

to establish, modify, or revoke a 

tolerance, the Agency consider 

‘‘available information’’ concerning the 

cumulative effects of a particular 

pesticide’s residues and ‘‘other 

substances that have a common 

mechanism of toxicity.’’ 

EPA has not found tricyclazole to 

share a common mechanism of toxicity 

with any other substances, and 

tricyclazole does not appear to produce 

a toxic metabolite produced by other 

substances. For the purposes of this 

tolerance action, therefore, EPA has 

assumed that tricyclazole does not have 

a common mechanism of toxicity with 

other substances. For information 

regarding EPA’s efforts to determine 

which chemicals have a common 

mechanism of toxicity and to evaluate 

the cumulative effects of such 

chemicals, see EPA’s Web site at 

http://www.epa.gov/pesticides/

cumulative. 

D. Safety Factor for Infants and 

Children 

1. In general. Section 408(b)(2)(C) of 

FFDCA provides that EPA shall apply 

an additional tenfold (10X) margin of 

safety for infants and children in the 

case of threshold effects to account for 

prenatal and postnatal toxicity and the 

completeness of the database on toxicity 

and exposure unless EPA determines 

based on reliable data that a different 

margin of safety will be safe for infants 

and children. This additional margin of 

safety is commonly referred to as the 

Food Quality Protection Act (FQPA) 

Safety Factor (SF). In applying this 

provision, EPA either retains the default 

value of 10X, or uses a different 

additional safety factor when reliable 

data available to EPA support the choice 

of a different factor. 

2. Prenatal and postnatal sensitivity. 

The toxicological database is complete 

with regard to pre-and postnatal 

toxicity. Although there was evidence of 

quantitative susceptibility in 

developmental rat and rabbit toxicity 

studies and qualitative susceptibility in 

the reproduction study, the degree of 

concern for the effects observed in the 

studies is low. There are clear NOAELs/ 

LOAELs for the fetal/pup effects seen 

and the effects in the developmental 

and reproduction studies were observed 

at levels significantly higher than the 

current PODs selected for risk 

assessment. Therefore, the acute and 

chronic dietary risk assessments are 

protective of potential fetal/offspring 

effects. 

3. Conclusion. EPA has determined 

that reliable data show the safety of 

infants and children would be 

adequately protected if the FQPA SF 

were reduced to 1X. That decision is 

based on the following findings: 

i. The toxicity database for 

tricyclazole is complete with regard to 

pre- and postnatal toxicity. 

ii. The endpoints and doses selected 

for risk assessment are protective of the 

increased qualitative susceptibility 

observed in the reproduction study in 

rats and the increased quantitative 

susceptibility seen in the developmental 

rat and rabbit studies; therefore the 

degree of concern for the susceptibility 

is low. 

iii. The endpoints and doses selected 

for risk assessment are also protective of 

the observed clinical signs in the 

database and neurotoxicity studies 

(acute, subchronic, and developmental) 

are not required; an immunotoxicity 

study is also not required. 

iv. There are no residual uncertainties 

identified in the exposure databases. 

The dietary food exposure assessments 

were performed based on 100% CT and 

tolerance-level residues. These 

assessments will not underestimate the 

exposure and risks posed by 

tricyclazole. 

IV. Other Considerations 

A. Analytical Enforcement Methodology 

Three methods have undergone 

successful independent laboratory 

validation for use as enforcement 

analytical methods. The first method is 

suitable for the analysis of both parent 

tricyclazole and the alcohol metabolite. 

It involves acid hydrolysis, extraction of 

residues into dichloromethane, clean-up 

by strong cation exchange (SCX) solidphase extraction, silylation of the 

alcohol metabolite, and analysis by gas 

chromatography/mass spectrometry 

(GC/MS). The validated limit of 

quantitation (LOQ) is 0.02 ppm for rice 

grain, polished rice, and rice husks, and 

0.05 ppm for rice forage, straw, and 

processed byproducts. The remaining 

two methods are multi-residue methods 

(DFG S19 and modified QuEChERS). 

DFG S19 uses acetone extraction, cleanup by partitioning and gel-permeation 

chromatography (GPC), and analysis by 

GC–MS. The validated LOQ is 0.02 ppm 

(parent only). The modified QuEChERS 

method uses acetonitrile/water 

extraction, clean-up by solid-phase 

partitioning, and analysis by liquid 

chromatography/mass spectrometry 

(LC–MS/MS). The validated LOQ is 0.01 

ppm each for the parent compound and 

the alcohol metabolite. 

The method may be requested from: 

Chief, Analytical Chemistry Branch, 

Environmental Science Center, 701 

Mapes Rd., Ft. Meade, MD 20755–5350; 

telephone number: (410) 305–2905; 

email address: residuemethods@

epa.gov. 

B. International Residue Limits 

In making its tolerance decisions, EPA 

seeks to harmonize U.S. tolerances with 

international standards whenever 


wreier-aviles on DSK6TPTVN1PROD with RULES
33468 Federal Register / Vol. 79, No. 112 / Wednesday, June 11, 2014 / Rules and Regulations 

possible, consistent with U.S. food 

safety standards and agricultural 

practices. EPA considers the 

international maximum residue limits 

(MRLs) established by the Codex 

Alimentarius Commission (Codex), as 

required by FFDCA section 408(b)(4). 

The Codex Alimentarius is a joint 

United Nations Food and Agriculture 

Organization/World Health 

Organization food standards program, 

and it is recognized as an international 

food safety standards-setting 

organization in trade agreements to 

which the United States is a party. EPA 

may establish a tolerance that is 

different from a Codex MRL; however, 

FFDCA section 408(b)(4) requires that 

EPA explain the reasons for departing 

from the Codex level. The Codex has not 

established a MRL for tricyclazole in 

rice. 

C. Revisions to Petitioned-For 

Tolerances 

EPA has not revised the tolerance 

levels, added or deleted tolerances, or 

otherwise modified the petition as 

proposed in the notice of filing. 

However, EPA has added the 

compliance statement which clarifies 

that the parent compound, tricyclazole, 

it so be measured for enforcement 

purposes. 

V. Conclusion 

Therefore, a tolerance is established 

for residues of tricyclazole, 5-methyl1,2,4-triazolo[3,4-b] benzothiazole, 

including its metabolites and 

degradates, in or on rice, grain at 3.0 

ppm. Compliance with the tolerance is 

to be determined by measuring only 

tricyclazole. 

VI. Statutory and Executive Order 

Reviews 

This final rule establishes tolerances 

under FFDCA section 408(d) in 

response to a petition submitted to the 

Agency. The Office of Management and 

Budget (OMB) has exempted these types 

of actions from review under Executive 

Order 12866, entitled ‘‘Regulatory 

Planning and Review’’ (58 FR 51735, 

October 4, 1993). Because this final rule 

has been exempted from review under 

Executive Order 12866, this final rule is 

not subject to Executive Order 13211, 

entitled ‘‘Actions Concerning 

Regulations That Significantly Affect 

Energy Supply, Distribution, or Use’’ (66 

FR 28355, May 22, 2001) or Executive 

Order 13045, entitled ‘‘Protection of 

Children from Environmental Health 

Risks and Safety Risks’’ (62 FR 19885, 

April 23, 1997). This final rule does not 

contain any information collections 

subject to OMB approval under the 

Paperwork Reduction Act (PRA) (44 

U.S.C. 3501 et seq.), nor does it require 

any special considerations under 

Executive Order 12898, entitled 

‘‘Federal Actions to Address 

Environmental Justice in Minority 

Populations and Low-Income 

Populations’’ (59 FR 7629, February 16, 

1994). 

Since tolerances and exemptions that 

are established on the basis of a petition 

under FFDCA section 408(d), such as 

the tolerance in this final rule, do not 

require the issuance of a proposed rule, 

the requirements of the Regulatory 

Flexibility Act (RFA) (5 U.S.C. 601 et 

seq.), do not apply. 

This final rule directly regulates 

growers, food processors, food handlers, 

and food retailers, not States or tribes, 

nor does this action alter the 

relationships or distribution of power 

and responsibilities established by 

Congress in the preemption provisions 

of FFDCA section 408(n)(4). As such, 

the Agency has determined that this 

action will not have a substantial direct 

effect on States or tribal governments, 

on the relationship between the national 

government and the States or tribal 

governments, or on the distribution of 

power and responsibilities among the 

various levels of government or between 

the Federal Government and Indian 

Tribes. Thus, the Agency has 

determined that Executive Order 13132, 

entitled ‘‘Federalism’’ (64 FR 43255, 

August 10, 1999) and Executive Order 

13175, entitled ‘‘Consultation and 

Coordination with Indian Tribal 

Governments’’ (65 FR 67249, November 

9, 2000) do not apply to this final rule. 

In addition, this final rule does not 

impose any enforceable duty or contain 

any unfunded mandate as described 

under Title II of the Unfunded Mandates 

Reform Act of 1995 (UMRA) (2 U.S.C. 

1501 et seq.). 

This action does not involve any 

technical standards that would require 

Agency consideration of voluntary 

consensus standards pursuant to section 

12(d) of the National Technology 

Transfer and Advancement Act of 1995 

(NTTAA) (15 U.S.C. 272 note). 

VII. Congressional Review Act 

Pursuant to the Congressional Review 

Act (5 U.S.C. 801 et seq.), EPA will 

submit a report containing this rule and 

other required information to the U.S. 

Senate, the U.S. House of 

Representatives, and the Comptroller 

General of the United States prior to 

publication of the rule in the Federal 

Register. This action is not a ‘‘major 

rule’’ as defined by 5 U.S.C. 804(2). 

List of Subjects in 40 CFR Part 180 

Environmental protection, 

Administrative practice and procedure, 

Agricultural commodities, Pesticides 

and pests, Reporting and recordkeeping 

requirements. 

Dated: May 29, 2014. 

Jack Housenger, 

Director, Office of Pesticide Programs. 

Therefore, 40 CFR chapter I is 

amended as follows: 

PART 180—[AMENDED] 

■ 1. The authority citation for part 180 

continues to read as follows: 

Authority: 21 U.S.C. 321(q), 346a and 371. 

■ 2. Section 180.678 is added to subpart 

C to read as follows: 

§ 180.678 Tricyclazole; tolerances for 

residues. 

(a) General. (1) Tolerances are 

established for residues of the fungicide 

tricyclazole, including its metabolites 

and degradates, in or on the 

commodities in the table below. 

Compliance with the tolerance levels 

specified below is to be determined by 

measuring only tricyclazole (5-methyl1,2,4-triazolo[3,4-b ]benzothiazole). 

Commodity Parts 

per million 

Rice, grain 1 .......................... 3.0 

1There are no U.S. Registrations on Rice 

as of June 11, 2014. 

(b) Section 18 emergency exemptions. 

[Reserved] 

(c) Tolerances with regional 

registrations. [Reserved] 

(d) Indirect or inadvertent residues. 

[Reserved] 

[FR Doc. 2014–13404 Filed 6–10–14; 8:45 am] 

BILLING CODE 6560–50–P 


wreier-aviles on DSK6TPTVN1PROD with RULES